Sökning: WFRF:(Pacquement Hélène)
> (2019) >
High-Dose Chemother...
-
Dirksen, UtaUniversity Hospital Essen
(författare)
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases : Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008
- Artikel/kapitelEngelska2019
Förlag, utgivningsår, omfång ...
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:ffec299a-f80f-4af6-9a59-121343a8b9b9
-
https://lup.lub.lu.se/record/ffec299a-f80f-4af6-9a59-121343a8b9b9URI
-
https://doi.org/10.1200/JCO.19.00915DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
PURPOSE: The R2Pulm trial was conducted to evaluate the effect of busulfan-melphalan high-dose chemotherapy with autologous stem-cell rescue (BuMel) without whole-lung irradiation (WLI) on event-free survival (main end point) and overall survival, compared with standard chemotherapy with WLI in Ewing sarcoma (ES) presenting with pulmonary and/or pleural metastases. METHODS: From 2000 to 2015, we enrolled patients younger than 50 years of age with newly diagnosed ES and with only pulmonary or pleural metastases. Patients received chemotherapy with six courses of vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) and one course of vincristine, dactinomycin, and ifosfamide (VAI) before either BuMel or seven courses of VAI and WLI (VAI plus WLI) by randomized assignment. The analysis was conducted as intention to treat. The estimates of the hazard ratio (HR), 95% CI, and P value were corrected for the three previous interim analyses by the inverse normal method. RESULTS: Of 543 potentially eligible patients, 287 were randomly assigned to VAI plus WLI (n = 143) or BuMel (n = 144). Selected patients requiring radiotherapy to an axial primary site were excluded from randomization to avoid excess organ toxicity from interaction between radiotherapy and busulfan. Median follow-up was 8.1 years. We did not observe any significant difference in survival outcomes between treatment groups. Event-free survival was 50.6% versus 56.6% at 3 years and 43.1% versus 52.9% at 8 years, for VAI plus WLI and BuMel patients, respectively, resulting in an HR of 0.79 (95% CI, 0.56 to 1.10; P = .16). For overall survival, the HR was 1.00 (95% CI, 0.70 to 1.44; P = .99). Four patients died as a result of BuMel-related toxicity, and none died after VAI plus WLI. Significantly more patients in the BuMel arm experienced severe acute toxicities than in the VAI plus WLI arm. CONCLUSION: In ES with pulmonary or pleural metastases, there is no clear benefit from BuMel compared with conventional VAI plus WLI.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Brennan, BernadetteRoyal Manchester Children's Hospital
(författare)
-
Le Deley, Marie CécileUniversity of Paris-Saclay,Centre Oscar Lambret
(författare)
-
Cozic, NathalieInstitut Gustave Roussy
(författare)
-
van den Berg, HenkEmma Children’s Hospital,Academic Medical Center of University of Amsterdam (AMC)
(författare)
-
Bhadri, VivekCancer Institute of New South Wales
(författare)
-
Brichard, BénédicteSaint-Luc University Hospital
(författare)
-
Claude, LineCentre Léon Bérard
(författare)
-
Craft, AlanUniversity of Newcastle upon Tyne
(författare)
-
Amler, SusanneUniversity of Münster,Friedrich Loeffler Institute
(författare)
-
Gaspar, NatalieInstitut Gustave Roussy
(författare)
-
Gelderblom, HansLeiden University Medical Centre
(författare)
-
Goldsby, RobertUCSF Benioff Children‘s Hospital,University of California, San Francisco
(författare)
-
Gorlick, RichardUniversity of Texas
(författare)
-
Grier, Holcombe E.Boston Children's Hospital
(författare)
-
Guinbretiere, Jean MarcHôpital René-Huguenin
(författare)
-
Hauser, PeterSemmelweis University
(författare)
-
Hjorth, LarsLund University,Lunds universitet,Sena effekter efter barncancerbehandling,Forskargrupper vid Lunds universitet,Late effects after childhood cancer treatment,Lund University Research Groups(Swepub:lu)pedi-lhj
(författare)
-
Janeway, KatherineBoston Children's Hospital
(författare)
-
Juergens, HeribertUniversity Hospital Münster
(författare)
-
Judson, IanRoyal Marsden NHS Foundation Trust
(författare)
-
Krailo, MarkUniversity of Southern California
(författare)
-
Kruseova, JarmilaCharles University in Prague
(författare)
-
Kuehne, ThomasUniversity Children's Hospital, Basel
(författare)
-
Ladenstein, RuthMedical University of Vienna
(författare)
-
Lervat, CyrilCentre Oscar Lambret
(författare)
-
Lessnick, Stephen L.Ohio State University
(författare)
-
Lewis, IanUniversity of Leeds
(författare)
-
Linassier, ClaudeUniversity Hospital of Tours
(författare)
-
Marec-Berard, PerrinePediatric Hematology and Oncology Institute (IHOPE)
(författare)
-
Marina, NeyssaFive Prime Therapeutics Inc
(författare)
-
Morland, BruceBirmingham Children's Hospital
(författare)
-
Pacquement, HélèneCurie Institute, Paris
(författare)
-
Paulussen, MichaelWitten/Herdecke University
(författare)
-
Randall, R. LorUniversity of California, Davis
(författare)
-
Ranft, AndreasUniversity of Paris-Saclay,Institut Gustave Roussy
(författare)
-
Le Teuff, GwénaëlUniversity of Birmingham
(författare)
-
Wheatley, KeithUniversity College London Hospital
(författare)
-
Whelan, JeremyUniversity of Pennsylvania,The Children's Hospital of Philadelphia
(författare)
-
Womer, RichardSeattle Children’s Hospital
(författare)
-
Oberlin, OdileInstitut Gustave Roussy
(författare)
-
Hawkins, Douglas S.Children's Hospital and Regional Medical Center, Seattle,Seattle Children’s Hospital
(författare)
-
University Hospital EssenRoyal Manchester Children's Hospital
(creator_code:org_t)
-
Euro-E.W.I.N.G. 99 Investigators
-
Ewing 2008 Investigators
Sammanhörande titlar
-
Ingår i:Journal of Clinical Oncology37:34, s. 3192-32020732-183X
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Dirksen, Uta
-
Brennan, Bernade ...
-
Le Deley, Marie ...
-
Cozic, Nathalie
-
van den Berg, He ...
-
Bhadri, Vivek
-
visa fler...
-
Brichard, Bénédi ...
-
Claude, Line
-
Craft, Alan
-
Amler, Susanne
-
Gaspar, Natalie
-
Gelderblom, Hans
-
Goldsby, Robert
-
Gorlick, Richard
-
Grier, Holcombe ...
-
Guinbretiere, Je ...
-
Hauser, Peter
-
Hjorth, Lars
-
Janeway, Katheri ...
-
Juergens, Heribe ...
-
Judson, Ian
-
Krailo, Mark
-
Kruseova, Jarmil ...
-
Kuehne, Thomas
-
Ladenstein, Ruth
-
Lervat, Cyril
-
Lessnick, Stephe ...
-
Lewis, Ian
-
Linassier, Claud ...
-
Marec-Berard, Pe ...
-
Marina, Neyssa
-
Morland, Bruce
-
Pacquement, Hélè ...
-
Paulussen, Micha ...
-
Randall, R. Lor
-
Ranft, Andreas
-
Le Teuff, Gwénaë ...
-
Wheatley, Keith
-
Whelan, Jeremy
-
Womer, Richard
-
Oberlin, Odile
-
Hawkins, Douglas ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Pediatrik
- Artiklar i publikationen
-
Journal of Clini ...
- Av lärosätet
-
Lunds universitet